Please login to read the full text of the article.
If you have no account yet, please register now.
Posted on
Previous Article
« Jaw necrosis risk in cancer patients on zoledronic acid varies with dosing, oral health Next Article
PPI therapy may render infliximab less effective in IBD patients »
« Jaw necrosis risk in cancer patients on zoledronic acid varies with dosing, oral health Next Article
PPI therapy may render infliximab less effective in IBD patients »
Related Articles
© 2021 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy